Genetic and pharmacological evaluation of cathepsin S in a mouse model of asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 1, 2011, Pages 81-87

  Deschamps, Kathleen ^a   Cromlish, Wanda ^a   Weicker, Sean ^a   Lamontagne, Sonia ^a   Huszar, Sarah L ^a   Gauthier, Jacques Yves ^a   Mudgett, John S ^b   Guimond, Alain ^c   Romand, Raymond ^c   Frossard, Nelly ^c   Percival, M David ^a   Slipetz, Deborah ^a   Tan, Christopher M ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b MERCK RESEARCH LABORATORIES   (United States)

^c INSTITUT CLINIQUE DE LA SOURIS   (France)

Author keywords

Asthma; Cathepsin S; Inflammation; Lung; Mouse

Indexed keywords

ANTIGEN; CATHEPSIN S; IMMUNOGLOBULIN E; OVALBUMIN; PROTEIN INHIBITOR;

AIRWAY; ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; GENETIC ANALYSIS; LUNG LAVAGE; MOUSE; NONHUMAN; PNEUMONIA; PREVENTIVE MEDICINE; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; ASTHMA; CATHEPSINS; DISEASE MODELS, ANIMAL; DRUG EVALUATION; HUMANS; MICE; MICE, KNOCKOUT; OVALBUMIN; PULMONARY EOSINOPHILIA; UP-REGULATION;

MURINAE; MUS;

EID: 79952921391     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2009-0392OC     Document Type: Article

References (24)

1. Vasiljeva O, Reinheckel T, Peters C, Turk D, Turk V, Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 2007;13:387-403. (Pubitemid 46477760)
2. Riese RJ, Wolf PR, Brömme D, Natkin LR, Villadangos JA, Ploegh HL, Chapman HA. Essential role for cathepsin S in MHC class IIassociated invariant chain processing and peptide loading. Immunity 1996;4:357-366. (Pubitemid 26174051)
3. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients. Pflugers Arch 2001;442:R204-R206. (Pubitemid 32906964)
4. Nakagawa TY, Brissette WH, Lira PD, Griffiths RJ, Petrushova N, Stock J, McNeish JD, Eastman SE, Howard ED, Clarke SR, et al. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999;10:207-217. (Pubitemid 29115626)
5. Biroc SL, Gay S, Hummel K, Magill C, Palmer JT, Spencer DR, Sa S, Klaus JL, Michel BA, Rasnick D, et al. Cysteine protease activity is up-regulated in inflamed ankle joints of rats with adjuvant-induced arthritis and decreases with in vivo administration of a vinyl sulfone cysteine protease inhibitor. Arthritis Rheum 2001;44:703-711. (Pubitemid 32234630)
6. Fajardo I, Svensson L, Bucht A, Pejler G. Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med 2004;170:477-484. (Pubitemid 39209127)
7. Lewis CC, Yang JY, Huang X, Banerjee SK, Blackburn MR, Baluk P, McDonald DM, Blackwell TS, Nagabhushanam V, Peters W, et al. Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med 2008;177:376-387. (Pubitemid 351317580)
8. Hirakawa H, Pierce RA, Bingol-Karakoc G, Karaaslan C, Weng M, Shi GP, Saad A, Weber E, Mariani TJ, Starcher B, et al. Cathepsin S deficiency confers protection from neonatal hyperoxia-induced lung injury. Am J Respir Crit Care Med 2007;176:778-785. (Pubitemid 47598479)
9. Riese RJ, Mitchell RN, Villadangos JA, Shi GP, Palmer JT, Karp ER, De Sanctis GT, Ploegh HL, Chapman HA. Cathepsin S activity regulates antigen presentation and immunity. J Clin Invest 1998;101:2351-2363. (Pubitemid 28270429)
10. Williams AS, Eynott PR, Leung SY, Nath P, Jupp R, De Sanctis GT, Resnick R, Adcock IM, Chung KF. Role of cathepsin S in ozone-induced airway hyperresponsiveness and inflammation. Pulm Pharmacol Ther 2008;22:27-32.
11. Zheng T, Zhu Z, Wang Z, Homer RJ, Ma B, Riese RJ Jr, Chapman HA Jr, Shapiro SD, Elias JA. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. J Clin Invest 2000;106:1081-1093.
12. Zheng T, Kang MJ, Crothers K, Zhu Z, Liu W, Lee CG, Rabach LA, Chapman HA, Homer RJ, Aldous D, et al. Role of cathepsin S-dependent epithelial cell apoptosis in IFN-gamma-induced alveolar remodeling and pulmonary emphysema. J Immunol 2005;174:8106-8115. (Pubitemid 40806322)
13. Gauthier JY, Black WC, Courchesne I, Cromlish W, Desmarais S, Houle R, Lamontagne S, Li CS, Massé F, McKay DJ, et al. The identification of potent, selective, and bioavailable cathepsin S inhibitors. Bioorg Med Chem Lett 2007;17:4929-4933. (Pubitemid 47187680)
14. Desmarais S, Black WC, Oballa R, Lamontagne S, Riendeau D, Tawa P, Duong le T, Pickarski M, Percival MD. Effect of cathepsin k inhibitor basicity on in vivo off-target activities. Mol Pharmacol 2008;73:147-156. (Pubitemid 350294206)
15. Bates J, Irvin C, Brusasco V, Drazen J, Fredberg J, Loring S, Eidelman D, Ludwig M, Macklem P, Martin J, et al. The use and misuse of Penh in animal models of lung disease. Am J Respir Cell Mol Biol 2004;31:373-374. (Pubitemid 39180309)
16. Adler A, Cieslewicz G, Irvin CG. Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol 2004;97:286-292. (Pubitemid 38802530)
17. Wilder JA, Collie DD, Wilson BS, Bice DE, Lyons CR, Lipscomb MF. Dissociation of airway hyperresponsiveness from immunoglobulin E and airway eosinophilia in a murine model of allergic asthma. Am J Respir Cell Mol Biol 1999;20:1326-1334. (Pubitemid 129503252)
18. Swedin L, Neimert-Andersson T, Hjoberg J, Jonasson S, van Hage M, Adner M, Ryrfeldt A, Dahlén SE. Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice. Eur Respir J 2009;34:200-208.
19. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9. (Pubitemid 28071253)
20. Henderson WR Jr, Chi EY, Albert RK, Chu SJ, Lamm WJ, Rochon Y, Jonas M, Christie PE, Harlan JM. Blockade of CD49d (alpha4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma. J Clin Invest 1997;100:3083-3092. (Pubitemid 28022846)
21. Henderson WR Jr, Tang LO, Chu SJ, Tsao SM, Chiang GK, Jones F, Jonas M, Pae C, Wang H, Chi EY. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108-116. (Pubitemid 34053366)
22. Holtzman MJ, Fabbri LM, O'Byrne PM, Gold BD, Aizawa H, Walters EH, Alpert SE, Nadel JA. Importance of airway inflammation for hyperresponsiveness induced by ozone. Am Rev Respir Dis 1983;127:686-690. (Pubitemid 13101546)
23. Horie T, Ohmori C, Koyama S, Saitoh O, Mutoh T, Okuma A, Okayasu M. Airway hyperresponsiveness after endotoxin inhalation depends on leukocyte infiltration. Tohoku J Exp Med 1988;156:109-120. (Pubitemid 19021110)
24. Therien AG, Bernier V, Weicker S, Tawa P, Falgueyret JP, Mathieu MC, Honsberger J, Pomerleau V, Robichaud A, Stocco R, et al. Adenovirus IL-13-induced airway disease in mice: a corticosteroid-resistant model of severe asthma. Am J Respir Cell Mol Biol 2008;39:26-35. (Pubitemid 351883955)